Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
December 26 2024 - 3:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of December, 2024
|
|
|
|
001-41208 |
|
|
(Commission File Number) |
|
NOVONIX LIMITED
(Translation of registrant’s name into English)
Level 38
71 Eagle Street
Brisbane, QLD 4000 Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBIT INDEX
Exhibit No. Description
Exhibit 99.1 ASX Announcement (ASX Approves SPP Waiver) announced December 24, 2024
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer |
|
|
|
Date: December 26, 2024
Asx Announcement
(ASX: NVX)
EXHIBIT 99.1
NOT FOR RELEASE TO US WIRE SERVICES OR DISTRIBUTION IN THE UNITED STATES
Share Purchase Plan – ASX Approves Waivers from Listing Rule 7.1 and 10.11
BRISBANE, Australia, December 24, 2024 - NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or “the Company”) a leading battery materials and technology company, is pleased to announce that the ASX has approved the waivers sought in relation to the Share Purchase Plan ("SPP") announced on 26 November 2024.
As previously announced, the Company applied for waivers from ASX Listing Rules 7.1 and 10.11 ("Waivers") to permit the Company to issue new shares under the SPP, without shareholder approval at an issue price of $0.60 per new share to eligible shareholders (being the same issue price as the institutional placement and the conditional placement). The Company applied for the Waivers as the offer price of $0.60 per new share under the SPP was less than 80% of the 5-day VWAP (calculated from 25 November 2024, being the last trading day immediately before the announcement of the SPP).
As a result of the waivers being granted, the Company will not require shareholder approval for the issue of new shares under the SPP at the upcoming Extraordinary General Meeting, expected to be held on 22 January 2025.
The Waivers from the ASX have been provided on the following conditions:
•the issue price of the shares offered under the SPP will be no less than the issue price of shares issued under the placements announced by the Company on 26 November 2024, being $0.60 per new share;
•the number of shares to be issued under the SPP is not greater than 30% of the number of fully paid ordinary shares already on issue; and
•with respect to Listing Rule 10.11 only, any scale back arrangements must not result in any director or associate of a director being scaled back on a more favourable basis than any other holder of a marketable parcel who is scaled back.
ACN 157 690 830, Level 38, 71 Eagle Street, Brisbane QLD 4000, Australia | novonixgroup.com
SPP Timetable
Following the receipt of the Waivers, the timetable for the SPP is as follows (per the SPP Offer Booklet released on 3 December 2024):
|
|
Event |
Date (and time if relevant) |
Record date for the SPP |
7:00pm on Monday, 25 November 2024 |
Dispatch of SPP Booklet and SPP opens |
10:00am on Tuesday, 3 December 2024 |
SPP closes |
5:00pm on Friday, 10 January 2025 |
SPP results announcement |
On or about Wednesday, 15 January 2025 |
Allotment date |
On or about Thursday, 16 January 2025 |
Commencement of trading of shares under the SPP and dispatch of holding statements |
On or about Friday, 17 January 2025 |
Shareholder meeting to approve conditional placement |
Wednesday, 22 January 2025 |
Note: All dates are indicative only and subject to change. All dates and times are Sydney time, unless otherwise specified. The commencement of trading and quotation of SPP shares is subject to confirmation from ASX. Subject to the requirements of the Corporations Act, the ASX Listing Rules and other applicable rules, NOVONIX reserves the right to amend this timetable at any time, including extending the period for the SPP or accepting late SPP applications, either generally or in particular cases, without notice.
This announcement has been authorised for release by Admiral Robert J Natter, USN Ret., Chairman.
About NOVONIX
NOVONIX is a leading battery technology company revolutionizing the global lithium-ion battery industry with innovative, sustainable technologies, high-performance materials, and more efficient production methods. The Company manufactures industry-leading battery cell testing equipment, is growing its high-performance synthetic graphite material manufacturing operations, and has developed a patented all-dry, zero-waste cathode synthesis process. Through advanced R&D capabilities, proprietary technology, and strategic partnerships, NOVONIX has gained a prominent position in the electric vehicle and energy storage systems battery industry and is powering a cleaner energy future.
To learn more, visit us at www.novonixgroup.com or on LinkedIn and X.
For NOVONIX Limited
ACN 157 690 830, Level 38, 71 Eagle Street, Brisbane QLD 4000, Australia | novonixgroup.com
Scott Espenshade, ir@novonixgroup.com (investors)
Stephanie Reid, media@novonixgroup.com (media)
ACN 157 690 830, Level 38, 71 Eagle Street, Brisbane QLD 4000, Australia | novonixgroup.com
Novonix (PK) (USOTC:NVNXF)
Historical Stock Chart
From Dec 2024 to Jan 2025
Novonix (PK) (USOTC:NVNXF)
Historical Stock Chart
From Jan 2024 to Jan 2025
